Sessions search

30
Apr 2017
18:15-19:00 CET
E-session 392038
ESO event

Expert:

Frederique Penault-Llorca, expert of session 'Molecular classification of lung cancer for clinical practice  (17LAM)'

Frederique Penault-Llorca
Centre Jean Perrin
Clermont-Ferrand, France

Share on:
Add to My Agenda

30
Apr 2017
18:15-19:00 CET
E-session 392039
ESO event

Expert:

Ricardo Mingarini Terra, expert of session 'Lung Cancer - Surgery  (17LAM)'

Ricardo Mingarini Terra
University of Sao Paulo Medical School
Sao Paulo, Brazil

Share on:
Add to My Agenda

30
Apr 2017
18:15-19:00 CET
E-session 392040
ESO event

Expert:

Felipe A. Calvo, expert of session 'Lung Cancer - Radiotherapy  (17LAM)'

Felipe A. Calvo
Hospital General Universitario Gregorio Marañón
Madrid, Spain

Share on:
Add to My Agenda

30
Apr 2017
18:15-19:00 CET
E-session 392041
ESO event

Expert:

Rolf A. Stahel, expert of session 'Non-Small cell lung cancer systemic therapy  (17LAM)'

Rolf A. Stahel
University Hospital
Zurich, Switzerland

Share on:
Add to My Agenda

30
Apr 2017
18:15-19:00 CET
E-session 392042
ESO event

Expert:

Rolf A. Stahel, expert of session 'Small cell lung cancer (17LAM)'

Rolf A. Stahel
University Hospital
Zurich, Switzerland

Share on:
Add to My Agenda

29
Apr 2017
18:15-19:00 CET
E-session 392030
ESO event

29
Apr 2017
18:15-19:00 CET
E-session 392031
ESO event

29
Apr 2017
18:15-19:00 CET
E-session 392032
ESO event

29
Apr 2017
18:15-19:00 CET
E-session 392033
ESO event

29
Apr 2017
18:15-19:00 CET
E-session 392034
ESO event

Expert:

Eric van Cutsem, expert of session 'Pancreatic and biliary tract cancer  (17LAM)'

Eric van Cutsem
University Hospital Gasthuisberg
Leuven, Belgium

Share on:
Add to My Agenda

29
Apr 2017
18:15-19:00 CET
E-session 392035
ESO event

Expert:

Rolf A. Stahel, expert of session 'ESMO guidance on evaluation of treatment benefit  (17LAM)'

Rolf A. Stahel
University Hospital
Zurich, Switzerland

Share on:
Add to My Agenda

29
Apr 2017
18:15-19:00 CET
E-session 392036
ESO event

Expert:

Franco Cavalli, expert of session 'MALT lymphoma  (17LAM)'

Franco Cavalli
Oncology Institute of Southern Switzerland
Bellinzona, Switzerland

Share on:
Add to My Agenda

29
Apr 2017
18:15-19:00 CET
E-session 392037
ESO event

Expert:

Paolo Casali, expert of session 'Sarcoma and GIST  (17LAM)'

Paolo Casali
National Cancer Institute - IRCCS Foundation
Milan, Italy

Share on:
Add to My Agenda

28
Apr 2017
18:15-19:00 CET
E-session 392020
ESO event

Expert:

Frederique Penault-Llorca, expert of session 'New classification of gynaecologic cancers (17LAM)'

Frederique Penault-Llorca
Centre Jean Perrin
Clermont-Ferrand, France

Share on:
Add to My Agenda

28
Apr 2017
18:15-19:00 CET
E-session 392021
ESO event

Expert:

Jan B. Vermorken, expert of session 'Ovarian Cancer: surgical and systemic treatment (17LAM)'

Jan B. Vermorken
University Hospital of Antwerp
Edegem, Belgium

Share on:
Add to My Agenda

28
Apr 2017
18:15-19:00 CET
E-session 392022
ESO event

Expert:

Ana Cecilia Rodriguez, expert of session 'Cervical Cancer: Primary and secondary prevention (17LAM)'

Ana Cecilia Rodriguez
National Cancer Institute of Costa Rica
San Jose, Costa Rica

Share on:
Add to My Agenda

28
Apr 2017
18:15-19:00 CET
E-session 392023
ESO event

Expert:

Maria Del Pilar Estevez Diz, expert of session 'Cervical Cancer: Systemic treatment (17LAM)'

Maria Del Pilar Estevez Diz
Cancer institute of Sao Paulo
Embu das Artes, Brazil

Share on:
Add to My Agenda

28
Apr 2017
18:15-19:00 CET
E-session 392024
ESO event

Expert:

Jan B. Vermorken, expert of session 'Management of endometrial cancer (17LAM)'

Jan B. Vermorken
University Hospital of Antwerp
Edegem, Belgium

Share on:
Add to My Agenda

28
Apr 2017
18:15-19:00 CET
E-session 392025
ESO event

Expert:

Fady B. Geara, expert of session 'Radiotherapy of gynaecological malignancies (17LAM)'

Fady B. Geara
American University of Beirut Medical Center
Riad El Solh, Beirut, Lebanon

Share on:
Add to My Agenda

28
Apr 2017
18:15-19:00 CET
E-session 392026
ESO event

Expert:

Nicholas Pavlidis, expert of session 'Cancer of Unknown Primary (17LAM)'

Nicholas Pavlidis
University of Ioannina
Ioannina, Greece

Share on:
Add to My Agenda

28
Apr 2017
18:15-19:00 CET
E-session 392027
ESO event

Expert:

Efrain Cambronero, expert of session 'H&N Cancer - When to operate? (17LAM)'

Efrain Cambronero
Centro Oncologico Dr. Chavarria Estrada
San Jose, Costa Rica

Share on:
Add to My Agenda

28
Apr 2017
18:15-19:00 CET
E-session 392028
ESO event

Expert:

Felipe A. Calvo, expert of session 'H&N Cancer - When to irradiate? (17LAM)'

Felipe A. Calvo
Hospital General Universitario Gregorio Marañón
Madrid, Spain

Share on:
Add to My Agenda

28
Apr 2017
18:15-19:00 CET
E-session 392029
ESO event

Expert:

Jan B. Vermorken, expert of session 'H&N Cancer - Systemic therapy and radio-chemotherapy (17LAM)'

Jan B. Vermorken
University Hospital of Antwerp
Edegem, Belgium

Share on:
Add to My Agenda

27
Apr 2017
18:15-19:00 CET
E-session 392007
ESO event

Expert:

Frederique Penault-Llorca, expert of session 'What a clinician needs to know about breast pathology and sample quality (17LAM)'

Frederique Penault-Llorca
Centre Jean Perrin
Clermont-Ferrand, France

Share on:
Add to My Agenda

27
Apr 2017
18:15-19:00 CET
E-session 392008
ESO event

Expert:

Giuseppe Curigliano, expert of session 'Breast Cancer - (Neo-)adjuvant chemotherapy and biological agents (17LAM)'

Giuseppe Curigliano
European Institute of Oncology
Milan, Italy

Share on:
Add to My Agenda

27
Apr 2017
18:15-19:00 CET
E-session 392009
ESO event

Expert:

Fatima Cardoso, expert of session 'Breast Cancer - (Neo-)adjuvant endocrine therapy (17LAM)'

Fatima Cardoso, Medical Oncologist
Champalimaud Clinical Center
Lisbon, Portugal

Share on:
Add to My Agenda

27
Apr 2017
18:15-19:00 CET
E-session 392010
ESO event

Expert:

Antonio Frasson, expert of session 'Optimal loco-regional management of breast cancer (17LAM)'

Antonio Frasson
Hospital Israelita Albert Einstein
São Paulo, Brazil

Share on:
Add to My Agenda

27
Apr 2017
18:15-19:00 CET
E-session 392011
ESO event

Expert:

Fatima Cardoso, expert of session 'Recommended management of HER-2+ advanced breast cancer (17LAM)'

Fatima Cardoso, Medical Oncologist
Champalimaud Clinical Center
Lisbon, Portugal

Share on:
Add to My Agenda

27
Apr 2017
18:15-19:00 CET
E-session 392012
ESO event

Expert:

Giuseppe Curigliano, expert of session 'Recommended management of triple-negative advanced breast cancer (17LAM)'

Giuseppe Curigliano
European Institute of Oncology
Milan, Italy

Share on:
Add to My Agenda

27
Apr 2017
18:15-19:00 CET
E-session 392013
ESO event

Expert:

Sandra Ximena Franco Millan, expert of session 'Recommended management of ER+ advanced breast cancer (17LAM)'

Sandra Ximena Franco Millan
Clinica del Country
Bogota, Colombia

Share on:
Add to My Agenda

27
Apr 2017
18:15-19:00 CET
E-session 392014
ESO event

Expert:

Gustavo Werutsky, expert of session 'The reality of clinical trials in Latin America (17LAM)'

Gustavo Werutsky
Latin American Cooperative Oncology Group
Porto Alegre, Brazil

Share on:
Add to My Agenda

27
Apr 2017
18:15-19:00 CET
E-session 392015
ESO event

27
Apr 2017
18:15-19:00 CET
E-session 392016
ESO event

Expert:

Fatima Cardoso, expert of session 'Management of cancer in young women (17LAM)'

Fatima Cardoso, Medical Oncologist
Champalimaud Clinical Center
Lisbon, Portugal

Share on:
Add to My Agenda

27
Apr 2017
18:15-19:00 CET
E-session 392017
ESO event

Expert:

Fedro A. Peccatori, expert of session 'Fertility preservation and cancer in pregnancy (17LAM)'

Fedro A. Peccatori
European Institute of Oncology
Milan, Italy

Share on:
Add to My Agenda

27
Apr 2017
18:15-19:00 CET
E-session 392018
ESO event

Expert:

Matti Aapro, expert of session 'Management and treatment of toxicity (17LAM)'

Matti Aapro, Medical Oncologist
Genolier Cancer Centre
Genolier, Switzerland

Share on:
Add to My Agenda

27
Apr 2017
18:15-19:00 CET
E-session 392019
ESO event

Expert:

Walter Zoss, expert of session 'Advancing cancer control in Latin America: the case of RINC/UNASUR (17LAM)'

Walter Zoss
RINC/UNASUR - Red de Institutos Nacionales de Cáncer / Network of National Cancer Institutes
Rio de Janiero, Brazil

Share on:
Add to My Agenda

26
Apr 2017
18:15-19:00 CET
E-session 392000
ESO event

Expert:

Carlos Eduardo Zuniga Orlich, expert of session 'The magnitude of the cancer problem in my country (17LAM)'

Carlos Eduardo Zuniga Orlich
Hospital San Juan de Dios
Uruca, Costa Rica

Share on:
Add to My Agenda

26
Apr 2017
18:15-19:00 CET
E-session 392001
ESO event

26
Apr 2017
18:15-19:00 CET
E-session 392002
ESO event

Expert:

Fady B. Geara, expert of session 'GU Cancer - Local therapy: Surgery and Radiotherapy (17LAM)'

Fady B. Geara
American University of Beirut Medical Center
Riad El Solh, Beirut, Lebanon

Share on:
Add to My Agenda

26
Apr 2017
18:15-19:00 CET
E-session 392003
ESO event

Expert:

Nicolas Mottet, expert of session 'GU Cancer - First-line endocrine treatment (17LAM)'

Nicolas Mottet
University Jean Monnet
Saint Etienne Cedex 2, France

Share on:
Add to My Agenda

26
Apr 2017
18:15-19:00 CET
E-session 392004
ESO event

Expert:

Nicolas Mottet, expert of session 'GU Cancer - Endocrine-resistant-refractory (17LAM)'

Nicolas Mottet
University Jean Monnet
Saint Etienne Cedex 2, France

Share on:
Add to My Agenda

26
Apr 2017
18:15-19:00 CET
E-session 392005
ESO event

Expert:

Nicolas Mottet, expert of session 'Treatment of bladder cancer (17LAM)'

Nicolas Mottet
University Jean Monnet
Saint Etienne Cedex 2, France

Share on:
Add to My Agenda

26
Apr 2017
18:15-19:00 CET
E-session 392006
ESO event

Expert:

Camilo Andrès Medina, expert of session 'Metastatic renal cancer: evidence-based treatment (17LAM)'

Camilo Andrès Medina
Fundacion Santa Fè
Bogota, Colombia

Share on:
Add to My Agenda
Top